| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |